These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10956318)

  • 1. Modulation of the renin-angiotensin system and retinopathy.
    Chaturvedi N
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i29-31:discussion i50. PubMed ID: 10956318
    [No Abstract]   [Full Text] [Related]  

  • 2. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
    Sjølie AK; Chaturvedi N
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibition: from viper to patient.
    Komajda M; Wimart MC
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i11-4:discussion i50. PubMed ID: 10956312
    [No Abstract]   [Full Text] [Related]  

  • 4. The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy.
    Jeganathan VS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):392-5. PubMed ID: 20939795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin inhibition: the holy grail of renin-angiotensin system blockade?
    McInnes GT
    J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
    Hasler C; Nussberger J; Maillard M; Forclaz A; Brunner HR; Burnier M
    Clin Pharmacol Ther; 2005 Nov; 78(5):501-7. PubMed ID: 16321616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
    Bilous R
    Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
    Andersen NH; Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

  • 10. Renin-angiotensin blockade in diabetic retinopathy.
    Ghattas A; Lip PL; Lip GY
    Int J Clin Pract; 2011 Feb; 65(2):113-6. PubMed ID: 21235693
    [No Abstract]   [Full Text] [Related]  

  • 11. Migraine prophylaxis with drugs influencing the renin-angiotensin system.
    Stovner LJ
    Eur J Neurol; 2007 Jul; 14(7):713-4. PubMed ID: 17594324
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.
    Mogensen CE; Neldam S; Tikkanen I; Oren S; Viskoper R; Watts RW; Cooper ME
    BMJ; 2000 Dec; 321(7274):1440-4. PubMed ID: 11110735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril.
    Nwachukwu DC; Aneke EI; Obika LF; Nwachukwu NZ
    Indian J Pharmacol; 2015; 47(5):540-5. PubMed ID: 26600645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
    Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H
    J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II, VEGF, and diabetic retinopathy.
    Williams B
    Lancet; 1998 Mar; 351(9105):837-8. PubMed ID: 9519992
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes complications and the renin-angiotensin system.
    Perkins BA; Aiello LP; Krolewski AS
    N Engl J Med; 2009 Jul; 361(1):83-5. PubMed ID: 19571288
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
    Fernandez Juarez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Cachofeiro V; Nieto J; Fernández Vega F; Tato A; Gutierrez E;
    Am J Kidney Dis; 2013 Feb; 61(2):211-8. PubMed ID: 22939518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II, VEGF, and diabetic retinopathy.
    Stoschitzky K
    Lancet; 1998 Mar; 351(9105):836-7. PubMed ID: 9519991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renin-angiotensin system].
    Ishida S
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():255-61. PubMed ID: 21667484
    [No Abstract]   [Full Text] [Related]  

  • 20. The renin angiotensin system and cardiovascular disease: hope or hype?
    Williams B
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):142-6. PubMed ID: 11967805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.